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The first total syntheses of the title fungal metabolites preussomerins F, K and L are described and their structures confirmed thereby. 
The syntheses were achieved following a versatile, unified non-biomimetic approach, which is easily extendable to prepare other 
known and novel members of this family. Key steps include the functionalisation of a 2-arylacetal anion, tandem one-pot Friedel-Crafts 
cyclisation-deprotection, regioselective substrate-directable hydrogenation and reductive opening of epoxides. 
Introduction 
In the last two decades, an extensive number of novel bis-naphthalene-based bioactive natural products have been isolated from fungi.1 
Biosynthetically, all these metabolites have a common origin, being generated by radical oxidative dimerisation of two naphthalene 
units via the 1,8-dihydroxynaphthalene (DHN) pathway.2 These growing new families of spirobisnaphthalene natural products have a 
unique structural feature involving two or three oxygen atoms acting as bridges connecting the original naphthalene subunits, which 
additionally exhibit an elaborate range of functionality patterns, generally involving partial saturation and further oxidation of the 
original aromatic cores. 
 
Most of these metabolites exhibit significant antifungal and antibacterial properties as a consequence of the interspecies competition 
among dung-inhabiting fungi in nature. However, the main biological interest concerns their capability to inhibit farnesyl-protein 
transferase (FTPase) in a highly selective fashion. This enzyme plays a critical role in the post-translational modification of a huge 
range of different proteins involved in intracellular signalling.3 In particular, FTPase attaches a farnesyl group to the thiol of a cysteine 
side chain of the Ras proteins. The cysteine residue belongs to a characteristic carboxy-terminal consensus sequence known as the 
CAAX box, whose prenylation is of great importance in cellular proliferation through membrane-binding processes. One of the 
substrates of the FTPase is the protein GTPase Ras, whose oncologically mutated form is found in over 30% of human cancers, 
particularly colon, lung, thyroid, bladder and pancreatic carcinomas, as well as in several types of leukaemias. As a result, FTPase 
inhibitors have been developed as potential antitumour therapeutic drugs, blocking the growth of human cancers.4 Recent studies have 
demonstrated that these compounds also constitute an efficient alternative therapy for the treatment of parasitic infections, especially 
against malaria.5 
 
These achievements have been mainly based on screening of natural products. Among the main representative groups of 
spirobisnaphthalene-derived naturally occurring substances with FTPase inhibitory activity are the diepoxins,6 palmarumycins,7 
spiroxins8 and preussomerins. Figure 1 illustrates a representative example of each family. 
 
This paper is concerned with the preussomerin family of natural products, which currently consists of 13 known fungal metabolites 
(Figure 2).9 Preussomerin A was the first member of the family to be isolated from the coprophilous fungus Preussia isomera by Gloer 
and co-workers in 1990.9a Subsequently, closely related preussomerins B-F were isolated from the same organism.9b Preussomerin D 
was also later isolated from the endophytic fungus Hormonema dematioides recovered from living plant tissue of a coniferous tree.9c 
New additions to this family of natural products came in 1994, when Singh and co-workers isolated preussomerins G, H, and I from an 
unidentified dung-inhabiting coelomycetous fungus (MF5916).9d An unusual new preussomerin analogue, characterised as 3’-O-
desmethyl-1-epi-preussomerin C, was next isolated from cultures of the coprophilous fungus Sporormiella vexans.9e Most recently, the 
latest additions to the family were reported by Krohn and co-workers, who isolated three new representatives, preussomerin J, K and L 
from a non-taxonomically characterised endophytic fungi (Mycelia sterila) from the roots of Atropa belladonna, confirming their 
absolute configuration by elegant comparison of experimental and theoretical CD spectra.9f Preussomerin K, as well as preussomerins 
E-I, were also isolated independently by Isaka and co-workers from a lichenicolous fungus Microsphaeropsis sp. BCC 3050.9g These 
authors have suggested that preussomerin I could be a by-product generated during the isolation protocol by Michael addition of MeOH 
to preussomerin G, while preussomerins J and K look to be real metabolites present in the crude strain extract before purification.9f,g 
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Figure 1 Representative members of the structurally-related naturally 
occurring substances with FTPase inhibitory activity. 
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From the structural point of view, all the members of the preussomerin family are characterised by the same key structural feature, 
having the original naphthalene units linked by three oxygen atoms, generating a bis-spiroacetal functionality. This remarkable head-to-
tail trioxabicyclo[3.3.1]nonane bis-acetal nucleus represents a unique and unexpectedly stable core in the natural kingdom, and 
constitutes an extremely challenging target for total synthesis.  
 
In all cases, the original naphthalene subunits have been partially reduced and oxidised. The original double bonds can be epoxidised, 
the epoxides then reductively opened or the carbonyl groups reduced to hydroxyl groups. 
 
As can be seen from Figure 2, preussomerins share a common bis-acetal skeleton. However, on the basis of the specific structural 
features of each member of the family, these compounds can be grouped into different subtypes. As a general rule, the northern 
hemisphere exhibits a common ,-epoxyketone or ,-epoxyalcohol unit. The differences dwell in the southern hemisphere of the 
molecule. The first set of compounds contain a conjugated ketone or allylic alcohol on this bottom subunit (Subtype I, preussomerins 
A, D, E, and G). An additional subgroup can be formed by preussomerin C, 3’O-desmethyl-1-epi-preussomerin C, and preussomerins I, 
J, K and L, which could be generated from the subtype I compounds by conjugate addition of oxygenated nucleophiles to the double 
bond or reductive-opening of a pre-existing epoxide on the subunit (Subtype II). A final subtype of preussomerins can be characterised 
by the presence of a ketone or alcohol functions on the benzylic position of the bottom hemisphere, without further functionality 
(Subtype III, preussomerins B, F and H). 
 
The first synthesis of any member of the preussomerin family was carried out by Heathcock and Chi, who reported an elegant total 
synthesis of (±)-preussomerins G and I.10 This approach followed an elegant putative biomimetic pathway based on the spontaneous 
oxidative dimerisation of naphthalenediol monoacetal (Scheme 1a). Further work by Barrett and co-workers described a unified 
synthesis of the palmarumycin and preussomerin natural products based again on a potentially biomimetic oxidative spirocyclisation as 
the key step. A previous asymmetric epoxidation of a palmarumycin-type intermediate enone allowed them access to enantiomerically 
pure (-)-preussomerin G.11  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 The currently known members of the preussomerin family of natural products.  
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The interest of our own group in preussomerins began as part of a program to prepare a range of different FTPase inhibitors for 
biological screening (e.g. manumycin A,12 palmarumycins CP1, CP2, and C11, CJ-12371 and deoxypreussomerin A
13). Our approach is 
based on a novel non-biomimetic strategy involving the use of 2-arylacetal anions obtained from a simplified bis-acetal (Scheme 1b).  
 
The proposed synthetic pathway described herein involves the formation of the bis-ketal in a single step and at an early stage of the 
synthesis, with subsequent elaboration of the outer fringes of the molecule. We initially investigated the use of this methodology for the 
construction of advanced synthetic preussomerin analogues containing the full carbon skeleton of the natural products14 and 
subsequently we applied these methods in the total syntheses of preussomerin K and L.15 Now, in this paper, we describe full details of 
our optimised and extended approach towards the total syntheses of preussomerins K and L as well as reporting the first synthesis of 
preussomerin F. 
 
Results and discussion 
 
Our approach is novel in that the bis-acetal nucleus of the preussomerins is formed at the start of the synthesis. Thus, the inexpensive 
and readily available 4-methoxyphenol was converted into multigram quantities of 5-methoxysalicylaldehyde 2 by an easy, magnesium 
methoxide-mediated ortho-specific formylation in good yield (>90% in a 30 g scale).16 Subsequent dimerisation of 2 smoothly 
provided the key racemic bis-acetal 3 in excellent yield following our previously described methodology (Scheme 2).14 A simplification 
of this earlier procedure allowed us to isolate 3 without extractive work-up by direct filtration and washing with petrol, avoiding the 
large scale recrystallisation from diethyl ether previously employed. We were then in a position to elaborate 3 into the full 
preussomerin skeleton. 
 
 
Acetal protons from the key intermediate 3 were predicted to be acidic due to donation of the resulting negative charge into the adjacent 
* anti-bonding orbitals, thus allowing sequential alkylation of the 2 and 2′-positions. Construction of the saturated rings A and D of 
the preussomerin skeleton should then be possible by further elaboration of newly introduced alkyl groups. 
 
We needed to introduce a functionalised alkyl group, which would allow us to subsequently elaborate the A and D rings of 
preussomerins. We chose first to utilise the allyl group. From the practical point of view, model studies demonstrated that the first 
deprotonation of the bis-acetal 3 could be achieved with n-BuLi. This carbanion was allylated easily in high yield. However, the second 
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Scheme 2 Reagents and conditions: i) Mg(OMe)2, paraformaldehyde, toluene, 90 ºC (>90%); ii) pivalic anhydride, H2SO4, rt, 1 h (90%). 
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Scheme 1 Key steps from the bio-mimetic approaches10,11 and via a 
bis-acetal intermediate.14 
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deprotonation was found to be more complex, and required the use of a stronger base. s-BuLi gave a significant improvement for this 
second deprotonation, allowing the introduction of a second allyl group. The sequential deprotonation-alkylation of intermediate 3 
allowed us to introduce a double allyl functionality giving 4, which was further converted into the bis-primary alcohol 5 using 9-BBN 
followed by oxidative work up (Scheme 3). 
 
Despite the success of the conversion of 4 into 5, we found that this procedure was practically difficult and gave variable yields. A 
higher yielding and more direct way of accessing diol 5 involving a one-pot deprotonation-alkylation sequence using oxetane as the 
electrophile was thus developed. The first alkylation proceeded smoothly using n-BuLi as base giving 6. The second alkylation used s-
BuLi as base. This latter alkylation must be carried out in the presence of a Lewis acid, such as BF3·etherate, to allow reasonable yields. 
The reaction was further improved by adding the oxetane–BF3·etherate system sequentially at low temperature (–100 ºC) and by using 
an excess of the electrophile for the second alkylation (Scheme 3). Under these conditions, the symmetrical diol 5 was provided in a 
moderate 52% overall yield, along with monoalcohol 6 (32% yield). 
 
Our next step was to convert diol 5 into its diacid derivative 7 with the aim of then carrying out a double Friedel-Crafts acylation on to 
the neighbouring aromatic cores, constructing the new rings A and D simultaneously. Oxidation of diol 5 was achieved by two 
procedures. We initially oxidised 5 using the Swern oxidation, giving the corresponding intermediate dialdehyde, which in a second 
step was oxidised further to the required diacid 7. The second oxidation was conducted using silver oxide, generated in situ from silver 
nitrate and potassium hydroxide (Scheme 4). However, an optimised transformation was achieved by direct Jones oxidation, which 
provided the diacid 7 in higher yields (95%) and shorter time and for a fraction of the cost. 
 
After activating the diacid 7 in situ as the acid chloride, treatment with a homogenous solution of AlCl3 in nitromethane at room 
temperature produced the Friedel-Crafts adduct 8 in good yield (75%) after 30 minutes. However, if the reaction was allowed to stand 
for longer time in the presence of an excess of AlCl3, two new compounds, characterised as 9 and 10, began to appear, indicating that 
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Scheme 3 Sequential functionalisation of the bis-acetal core. Reagents 
and conditions: i) a) n-BuLi, THF, -78 ºC; b) Allyl bromide; c) s-Buli, 
THF, -78 ºC; d) Allyl bromide, (52%); ii) a) 9-BBN, THF, 0º C; b) 
NaOH, H2O2 (62%). One-pot procedure. Reagents and conditions: iii) n-
BuLi, THF, -78 ºC, 30 min; then oxetane, BF3.Et2O, from -100 to -40 ºC 
over 90 min; then s-BuLi, THF, -78 ºC, 30 min; then oxetane, BF3.Et2O, 
from -100 to -40 ºC over 4 h, (52% 5, 32% 6). 
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Scheme 4 Reagents and conditions: i) Jones’ reagent, acetone rt, 10 min 
(95%); ii) (COCl)2, DMSO, dichloromethane, -70 ºC, then Et3N, -60 ºC; 
iii) AgNO3, aq. KOH, MeOH, THF (85%, two steps). 
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Scheme 5 Reagents and conditions: i) a) (COCl)2, DMF (cat), 
dichloromethane, 0 ºC to rt, 1 h; b) AlCl3, MeNO2, dichloromethane, 20 
h, then 20% aq. Rochelle’s salt (10% 8; 44% 9; 33% 10). 
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after a rapid cyclisation (less than 1 hour to completion), the remaining Lewis acid slowly carried out the cleavage of the phenolic 
methoxy groups (Scheme 5). Compounds 8-10 all contain the full preussomerin hydrocarbon skeleton but, additionally, in compound 9 
the symmetry has been broken. Thus, in a one-pot fashion both the critical intramolecular cyclisation as well as the monodeprotection 
of one the phenolic moieties has been achieved. The reaction has proved to be easily scalable to provide a 44% yield of compound 9. 
Both by-products 8 and 10 are easily separable from 9 and can be recycled to improve the overall yield. 
We next investigated the deoxygenation of the free phenol group on intermediate 9. This transformation was accomplished by an initial 
activation of the phenol group as the triflate 11, which was removed by hydrogenation using Pearlman’s catalyst to provide 12 in good 
overall yield (Scheme 6). 
 
Having established an easily scalable route to 12, our attention became focused on its conversion into dienone 15. Early investigations 
regarding the direct dehydrogenation were unsuccessful (e.g. benzeneseleninic anhydride,13 DDQ, etc.). When we applied the IBX-
mediated direct dehydrogenation method recently described by Nicolaou and co-workers,17 we found the monounsaturated compound 
13 was the main product, while most of the starting material remained unreacted (or was finally degraded if reaction conditions were 
forcing or the time prolonged) (Scheme 6). 
 
This problem was circumvented by preparation of the disilyl enol ether 14, which was converted into dienone 15 (Scheme 6). We again 
investigated the use of the IBX-MPO complex,18 which generated the dienone 16, but only in moderate 41% yield (plus 20% recovered 
12). However, the same transformation could be accomplished efficiently under the classical conditions of the Saegusa reaction,19 
yielding dienone 15 in 91% yield using super-stoichiometric Pd(OAc)2 (2.2 equiv.). Catalytic conditions were unsuccessful for this 
reaction.20 
 
At this stage, we focused our attention on preussomerins K and L. The special structural features of these molecules (Subtype II 
targets) lie in the characteristic -hydroxyketone moiety. Two approaches were examined to install this moiety. We first investigated 
the conjugate addition of oxygenated nucleophiles onto the enone systems (Scheme 7).  
 
Conjugate addition of methanol was achieved cleanly converting 15 into its -methoxy adduct 16.10 It must be noted at this point that 
the conjugate addition of the oxygenated nucleophiles proceeded with complete stereoselectivity on the less hindered faces of the 
dienone 15. The strong steric hindrance provided by the -(O3)oxygen makes the top face of the preussomerin core inaccessible to 
nucleophiles due to the unique spatial disposition of the two planar subunits of the molecule, which are almost perpendicular to each 
other. 
 
Unfortunately, demethylation of the adduct 16 resulted in extensive degradation of the starting material due to the remarkable resistance 
of the -methoxy group to cleavage under all conditions attempted. For this reason, we investigated the epoxidation of dienone 15. This 
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Scheme 6 Reagents and conditions: i) Tf2O, pyridine, dichloromethane,  -10 ºC to rt; ii) H2, 20% Pd(OH)2/C, Et3N, MeOH/EtOAc (3:1) v/v, (82%, two 
steps); iii) TMSOTf, 2,6-lutidine, 0 ºC to rt, 1 h; iv) Pd(OAc)2 (2.2 equiv), CH3CN, rt, 16 h (91%, two steps). v) IBX-MPO (3 equiv), DMSO, rt, 90 min 
(41%) (61% based on recovered 12); vi) IBX, toluene, DMSO, 80 ºC, 3 d (10%). 
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was successfully carried out using excess tert-butyl hydroperoxide (TBHP) in presence of the guanidine base 1,3,4,6,7,8-hexahydro-
2H-pyrimido[1,2-a]pyrimidine (TBD) following our own methodology21 to yield the bis-,-epoxyketone 17 in excellent yield with 
total stereoselectivity. In the subsequent step, ring-opening of the diepoxide using a selenium-mediated process22 proved 
straightforward and the bis--hydroxyketone 18 could be obtained in good yield by a regio- and stereoselective transformation. 
Removal of the methyl ether group on the phenolic oxygen in 18 was achieved successfully under very mild conditions using 9-I-
BBN23 affording the first of the natural products, preussomerin L. 
 
The structural identities of 17 and 18 were confirmed by X-ray crystallographic analysis. The ORTEP24 representations are shown in 
Figure 3.25 It should be noted that both structures are exactly in accordance with those reported for the natural products (with the two 
aromatic rings almost perpendicular to each other). 
The epoxide pathway was also used to access preussomerin K. We anticipated that the ,-epoxyketones from each subunit of the 
intermediate 17 would have different reactivity. The presence of an electron-donating methoxy group on the northern hemisphere of the 
molecule influences the electronic behaviour of the vicinal carbonyl group, making it less electron-deficient than the carbonyl in the 
southern hemisphere of the molecule. We therefore treated 17 with a sub-stoichiometric amount of organoselenide and, as predicted, 
reduction of diepoxide 17 generated predominantly compound 19 (54%). The monoepoxide 20 and recovered 17 could be recycled to 
afford additional amounts of diol 18 (needed for preussomerin L synthesis). 
 
Attempts to demethylate 19 (9-I-BBN, bromocatechol borane, etc.) resulted in extensive degradation of the extremely sensitive epoxide 
moiety. We circumvented this limitation by using excess boron tribromide, which provided the intermediate bromohydrin 21. The 
epoxide was then regenerated by basic treatment of 21 affording preussomerin K (Scheme 7). 
 
The data from the synthetic samples of preussomerin K and L matched with those obtained by analysing authentic samples of the 
natural compounds kindly provided by Prof. K. Krohn. Table 1 shows the 13C NMR shifts found from synthetic preussomerin K and 
those reported for the natural product.9g 
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Scheme 7 Reagents and conditions: i) LiOMe, MeOH, rt, 5 min (quantitative); ii) TBHP, TBD, toluene, 0 ºC to rt, 1 h (90%); iii) (PhSe)2 (2.5 equiv), 
NaBH4, EtOH, 0 ºC to rt, 1 h (67%); iv) 9-I-BBN, dichloromethane, 0 ºC to rt, 1 h (42%) (69% based on recovered 18); v) (PhSe)2 (0.9 equiv), NaBH4, 
EtOH, AcOH, 0 ºC to rt, 1h, (54% 19); vi) BBr3 (4 equiv), dichloromethane, -78 ºC to rt, 1 h; vii) LiOMe, t-BuOH, rt, 10 min (50%, plus 17% 
preussomerin L). 
 
Figure 3 ORTEP drawing of compound 17 and 18 (50% probability thermal ellipsoids). 
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Next, we wished to extend this methodology to access Subtype III preussomerins. This required the regioselective reduction of the 
carbonyl on the southern hemisphere of the molecule. In our case, we found the catalytic hydrogenation was the key method for a 
simple and practical solution to this problem. During the deoxygenation of triflate 11, we found that a new more polar compound began 
to appear after prolonged reaction times (>24 h). This compound was characterised as 22 (Scheme 8). Over-reduction occurred in a 
regioselective fashion at the southern carbonyl group. This serendipitous finding allowed us to access a new key intermediate from 
which we were able to synthesise a Subtype III preussomerin.  
 
We therefore concentrated our attention on the development of the optimal conditions for the efficient conversion of 11 into 22. The 
original conditions (Pearlman’s catalyst) were very slow. Only extended reaction times (>5 d) allowed 22 to be obtained in moderate 
yield. We therefore screened different catalysts, finding that 5% Pd on activated charcoal produced an efficient over-reduction and 
generated 22 in 50% yield after 20 hours. Another product of over-reduction was found to be formed under these conditions, being 
characterised as the diol 23. Its amount increased as the reaction time was extended, but by limiting the reaction time to 20 hours less 
than 10 % was obtained (See Scheme 8).  
 
This transformation is quite versatile in terms of reuse of the over-reduced products. Compound 23 can be straightforwardly oxidised to 
form 12 by Jones oxidation and 12 can be hydrogenated to give 22 with Et3N/MeOH/EtOAc as solvent. However, hydrogenation of 12 
under standard conditions afforded an unexpected result. In the absence of triethylamine, the rapid deoxygenation of both carbonyls 
occurred, affording 24 in quantitative yield (Scheme 8). The use of triethylamine as co-solvent allowed controlled reduction, giving 22 
in 50% yield (8-12 h). The role of triethylamine still remains unclear, but is probably related to a poisoning effect on the catalyst. 
 
With the key intermediate 22 in hand, we embarked on a synthesis of preussomerin F. The approaches followed are shown in Scheme 
9. First protection of the benzylic hydroxyl group was carried out to preclude any risk of elimination during the subsequent reactions. 
Protection as the MOM derivative proceeded smoothly affording 25a in high yield.  
 
Table 1 13C-NMR data comparison of natural and synthetic 
preussomerin K9g 
 Position                         Chemical shift                     
                                       Natural   Synthetic 
 
1     195.4   195.4 
2       52.1     52.1 
3       53.5     53.5 
4       93.6     93.7 
5     115.6   115.6 
6     142.8   142.8 
7     126.4   126.5 
8     121.4   120.8 
9     156.1   156.2 
10     110.1   110.2 
 
1'     193.1   193.1 
2′       41.3     41.2 
3′       70.1     70.2 
4′       94.4     94.4 
5′     119.2   119.2 
6′     149.8   149.8 
7′     121.5   121.5 
8′     131.3   131.3 
9′     120.8   121.4 
10′     130.7   130.7 
Data in ppm. Spectra recorded in CDCl3 (100 MHz) 
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Scheme 8 Reagents and conditions: i) H2 (1 atm), 5% Pd/C, Et3N, 
MeOH/EtOAc (3:1) v/v, 20 h, (50% 22); ii) H2 (1 atm), 5% Pd/C, 
MeOH/EtOAc (3:1) v/v, 24 h (quantitative yield); iii) as i), but Et3N used 
as co-solvent (50%); iv) Jones’ reagent, acetone, rt, 10 min (>90%) 
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The next step involved generation of the enone. Taking advantage of our previous experience in this field, we attempted the Saegusa 
reaction via the silyl enol ether derived from 25a. Surprisingly, the mild method used before (TMSOTf, 2,6-lutidine) failed when it was 
applied to 25a. The best results were obtained using sodium hexamethyldisilazane in THF (1.1 equiv.) at -40 ºC, trapping the enolate in 
situ with excess TMSCl. The intermediate silyl enol ether proved to be extremely sensitive. Removal of the solvent without work-up, 
redissolving the crude product in acetonitrile and treatment with Pd(OAc)2 without additional purification gave enone 26a in 54% yield 
with 25a being recovered in 25% yield (this could be recycled increasing the overall yield). Epoxidation of enone 26a proceeded 
efficiently using the guanidine base-mediated epoxidation affording 27a in high yield.  
 
The structure of 27a was confirmed by X-ray crystallographic analysis. The ORTEP24 representation is shown in Figure 4.26 As in the 
previous series, the two quasi-planar subunits are almost perpendicular to each other. 
 
Deprotection of the MOM group in 27a proceeded smoothly under mild conditions providing 9-O-methoxy preussomerin F (28). 
Removal of the methoxy protecting group of 28 was attempted using the same strategy described earlier via the intermediate 
bromohydrin and subsequent epoxide regeneration with base. Unfortunately, treatment of 28 with boron tribromide produced extensive 
degradation of the epoxide without formation of the desired bromohydrin. No method employed gave clean demethylation of the 
phenol without degrading the epoxide.  
 
 
We therefore turned our attention to a modified route in which the methyl ether protecting group was removed prior to the generation of 
the epoxide.  
 
Demethylation was carried out on 25a using lithium iodide in refluxing pyridine, affording 25b in 93% yield. The Saegusa reaction was 
repeated with this substrate producing enone 26b in 68% yield. Unfortunately, epoxidation failed on this substrate despite extensive 
experimentation. We therefore realised the need to protecting the phenol group for the epoxidation. We for that reason introduced on 
25b a second MOM group converting it cleanly into 25c (85%). Saegusa reaction on 25c allowed the preparation of enone 26c and 
epoxidation now efficiently afforded 27c.  
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Scheme 9 Reagents and conditions: i) MOMCl, Hunig’s base, dichloromethane, 0º to rt, 2-24 h (25a 94%, 25c 85%); ii) LiI (5 equiv), pyridine, reflux, 
20 h (93%); iii) a) NaHMDS, THF, -40 ºC; b) TMSCl; c) Pd(OAc)2, CH3CN, 16-18 h (50-75%); iv) TBHP, TBD, toluene, 0 ºC to rt, (90-93%); v) HCl, 
i-PrOH, 50 ºC, 5-8 h, (66-75%). 
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The final acid-catalysed deprotection of MOM groups in 27c proved to be troublesome due to the high lability of epoxide. While the 
phenol-protecting MOM is easily and rapidly removed, the benzylic MOM removal requires heating and longer reaction times to be 
completed, thus damaging the sensitive epoxide. However, after extensive experimentation, we were able to develop optimised 
conditions, which afforded preussomerin F in good yield (66%) with diol 29 as the only by-product in 34% yield (Scheme 9). The 
authenticity of preussomerin F was established by full characterisation and comparison of spectroscopic data with those reported (e.g. 
signals due to epoxide: H (methanol-d4) 4.25 (J = 4.2 Hz, C2-CH) and 3.84 (J = 4.0 Hz, C3-CH); C (methanol-d4) 54.9 (C2) and 53.2 
(C3); lit.,9b H (methanol-d4) 4.27 (J = 4.2 Hz, C2-CH) and 3.84 (J = 3.9 Hz, C3-CH); C (methanol-d4) 54.8 (C2) and 53.2 (C3)). 
 
Conclusion 
 
In summary, we have successfully synthesised the racemic natural products preussomerin F (3% overall yield, 13 steps) and 
preussomerins K and L (4% overall yields in both cases, 11 and 10 steps, respectively) from very simple, inexpensive and easily 
available starting materials through the application of a straightforward non-biomimetic strategy with the functionalisation of 2-
arylacetal anions, simultaneous one-pot Friedel-Crafts cyclisation-deprotection and substrate-regiocontrolled hydrogenation as the key 
steps of the syntheses. The above methodology is extremely versatile and could be used for the preparation of a range of preussomerin 
analogues by simple functional group interconversion. Further studies to develop asymmetric approaches to enantiomerically pure 
compounds are currently under investigation and will be reported in due course.  
 
Experimental 
General Information 
All reactions were carried out in oven-dried glassware under an inert atmosphere (argon or nitrogen) unless stated otherwise. All 
solvents were freshly distilled prior to use when anhydrous conditions were required. THF was distilled from sodium/benzophenone, 
and acetonitrile, dichloromethane, methanol, ethanol and toluene from CaH2. Chemicals were purchased from commercial suppliers 
and were used as received without further purification. Analytical thin-layer chromatography (TLC) was performed on precoated 
aluminium silica gel plates (Merck 60F254, 0.25 mm). Product spots were visualised under UV light (lamp at 254 or 360 nm), or 
dipped into any of the following solutions: phosphomolybdic acid (PMA), 2,4-dinitrophenylhydrazine (DNP) or vanillin, followed by 
heating with a hot gun. Flash column chromatography was performed on silica gel (Merck, 230-400 mesh). Melting points were 
measured on an electrothermal IA9100 digital melting point apparatus and are uncorrected. Infrared (IR) spectra were recorded on an 
ATI Mattson Genesis FT-IR spectrometer; deposited samples were prepared by dissolving solids in a small volume of CHCl3 and 
forming a thin film on a NaCl plate by allowing the solvent to evaporate. 1H and 13C NMR spectra were taken at room temperature 
(21ºC unless otherwise noted) in CDCl3, acetone-d6 or methanol-d4 on Jeol GX-270, GX-400 or Brücker AMX 500 MHz 
spectrometers. Chemical shifts are reported in parts per million (ppm) using as internal reference the residual peaks of chloroform ( 
7.26 and 77.0 ppm), acetone-d6 ( 2.04 and 29.8 ppm) or methanol-d4 ( 3.35 and 49.3 ppm). J values are given in Hz. Carbon and 
proton assignments were based on 13C-1H Heteronuclear Singlet Quantum Correlation (HSQC), Heteronuclear Multiple Quantum 
Correlation (HMQC) and gradient-COSY experiments including large range correlation experiments (HMBC). Stereochemical 
configuration of key intermediates was determined by selective nOe irradiation of the selected peaks. Low resolution electron impact 
mass spectra were recorded on a Kratos MS 25 spectrometer. Both low and accurate mass with CI and FAB techniques were carried out 
on a Micromass Autospec spectrometer. The following abbreviations were used for solvents: PE (Petroleum ether bp 60-40 ºC), EtOAc 
(ethyl acetate), DCM (dichloromethane), THF (tetrahydrofuran) and DMF (dimethylformamide). All products were stored at –20ºC 
under argon. 2-Hydroxy-5-methoxybenzaldehyde (2) was prepared from 4-methoxyphenol and paraformaldehyde according to the 
reported method.16 Numbering of the preussomerins is in accordance with the numbering of the original reference (See Figure 2).9a  
 
6H,12H-2,8-Dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 3 
 
To a solution of 2-hydroxy-5-methoxybenzaldehyde (2) (16.92 g, 111 mmol) in pivalic anhydride (20.7 g, 22.6 mL, 111 mmol) at 0 ºC 
(ice bath), under efficient stirring, was added three drops of concentrated H2SO4 (catalytic amount). A white precipitate was formed 
 
 
 
 
 
 
 
 
 
Figure 4 ORTEP drawing of compound 27a (50% probability thermal ellipsoids). 
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almost immediately. After 1 h, the crude reaction was filtered and repeatedly washed with cold PE. The white precipitate was pressed 
between two pieces of filter paper and crushed with a spatula until it was finely dispersed as a white solid, which was dried overnight in 
vacuo affording a white powder (14.2 g, 89% yield). Recrystallisation from hot diethyl ether afforded the title compound 3 as large 
translucid crystals; Rf = 0.51 (PE/ EA (1:1)); mp 113-114 ºC; (Found: C, 67.03%; H, 4.79%; required for C16H14O5, C, 67.13%; H, 
4.93%); max(film)/cm
-1 1498, 1430, 1262, 1220, 1158, 1060, 1035, 985, 963; H (270 MHz; CDCl3): 3.75 (6 H, s, 2 x OCH3), 6.26 (2 
H, s, C7-CH, C7’-CH) and 6.85-6.8 (6 H, m, C2-CH, C3-CH, C5-CH, C2’-CH, C3’-CH, C5’-CH); C (67.5 MHz; CDCl3) 55.6 (2 x 
OMe), 90.1 (C7, C7’), 111.1 (C2, C2’), 117.3 (C3, C3’), 117.7 (C5, C5’), 120.3 (C6, C6’), 144.3 (C4, C4’) and 154.1 (C1, C1’); m/z 
(EI) Calcd for C16H14O5 [M
+] 286.08412; Found: 286.08414 (+0.1 ppm); 286 [M+] (80), 150 (100). 
 
6H,12H-6,12-Di-(3’-hydroxypropyl)-2,8-dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 5 and 6H,12H-6-(3’-Hydroxypropyl)-
2,8-dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 6  
 
A solution of bis-acetal 3 (1.72 g, 6.0 mmol) in THF (40 mL) was cooled to –78 ºC under constant pass of a stream of nitrogen and 
treated with n-BuLi (2.3 M in hexanes, 2.9 mL, 6.7 mmol). The reaction mixture was stirred at –78 ºC for 30 min to provide a deep 
purple solution. The flask was cooled further to –100 ºC (ethanol/liquid nitrogen mixture) and treated with oxetane (0.4 mL, 6.0 mmol), 
followed by slow addition of BF3·Et2O (830 µL, 6.6 mmol), maintaining the temperature below –90 ºC. The flask was allowed to 
slowly warm to –40 ºC over 90 min and the resultant orange solution stirred at –40 ºC for a further hour. The mixture was cooled then 
again to –78 ºC and slowly treated with s-BuLi (1.3 M in hexanes, 6.0 mL, 7.8 mmol) to provide a very dark solution. After stirring at –
78 ºC for 30 min, the solution was cooled to –100 ºC and oxetane added (1.2 mL, 18 mmol), followed by slow addition of BF3·Et2O 
(2.4 mL, 19 mmol), maintaining the temperature below –90 ºC. The flask was allowed to warm to –40 ºC over 3 h and the resultant 
orange solution was stirred at –40 ºC for a further hour. The reaction mixture was quenched by addition of a saturated aqueous solution 
of NaHCO3 (50 mL) and ethyl acetate (80 mL). The layers were separated, the organic layer washed with additional saturated NaHCO3 
solution (40 mL) and brine (40 mL) and dried over sodium sulfate. The organic extracts were filtered and the solvent evaporated in 
vacuo. The crude mixture was purified by flash column chromatography on silica gel (eluting with a polar gradient PE/EtOAc 50 to 
90% EtOAc), to provide first the mono-alcohol 6 (0.66 g, 32%), followed by the title compound diol 5 (1.25 g, 52%). Both compounds 
were isolated as extremely viscous oils and subsequently converted to pale yellow stable foams by repeated evaporation from DCM and 
high vacuum drying. 
 
5, Rf = 0.57 (EtOAc); max(film)/cm
-1 3339, 2943, 1496, 1427, 1276, 1226, 1174, 1039, 1005, 953; H (270 MHz; CDCl3) 1.67 (4H, m, 
C9-CHa, C9’-CHb, 2 x OH), 1.82 (2 H, m, C9-CHa, C9’-CHa), 2.27 (2 H, m, C8-CHb, C8´CHb), 2.46 (2 H, m, C8-CHa, C8’-CHa), 3.68 
(4 H, m, C10-CH2, C10’-CH2), 3.72 (6 H, s, 2 x OCH3) and 6.8-6.7 (6 H, m, C2-CH, C3-CH, C5-CH, C2’-CH, C3’-CH, C5’-CH); H 
(270 MHz; acetone-d6) 1.85-1.45 (4 H, m, C9-CH2, C9’-CH2), 2.5-2.3 (4 H, m, C8-CH2, C8’-CH2), 3.65-3.58 (4 H, m, C10-CH2, C10’-
CH2), 3.70 (6 H, s, 2 x OCH3), 6.72 (2 H, dd, J = 9 and 1, C2-CH, C2’-CH), 6.79 (2 H, dd, J = 9 and 2.5, C3-CH, C3’-CH), and 6.95 (2 
H, d, J= 2.5, C5-CH, C5’-CH); C (67.5 MHz, acetone-d6) 27.4 (C9, C9’), 34.9 (C8, C8’), 55.9 (2 x OMe), 62.2 (C10, C10’), 98.3 (C7, 
C7’), 111.0 (C2, C2’), 117.3 (C3, C3’), 117.8 (C5, C5’), 123.8 (C6, C6’), 147.2 (C4, C4’) and 155.1 (C1, C1’); m/z (FAB) Calcd for 
C22H26O7Na [M+Na
+] 425.15762; Found: 425.15780 (+0.4 ppm). 
 
6, Rf = 0.20 (PE/EtOAc (1:1)); mp 116-117 ºC; max(film)/cm
-1 1497, 1466, 1428, 1274, 1229, 1201, 1059, 1036, 999, 953; H (270 
MHz, CDCl3) 1.79 (1 H, m, C9-CHa), 1.66 (1 H, m, C9-CHb), 2.13 (1 H, br s, OH), 2.28 (1 H, ddd, J = 14, 9.5 and 5, C8-CHb), 2.46 (1 
H, ddd, J = 14, 9.5 and 5, C8-CHa), 3.66 (2 H, m, C10-CH2), 6.23 (1 H, s, C7’-CH)), 3.69 (6 H, s, 2 x OCH3), 6.77 (6 H, m, C2-CH, 
C3-CH, C5-CH, C2’-CH, C3’-CH, C5’-CH); H (270 MHz; acetone-d6) 2.5-2.3 (2 H, m, C8-CH2), 1.77-1.42 (2 H, m, C9-CH2), 3.718 
(3 H, s, OCH3), 3.61-3.56 (2 H, m, C10-CH2), 3.722 (3 H, s, OCH3), 6.37 (1 H, s, C7’-CH), 6.74 (1H, d, J = 8.5, C2-CH or C2’-CH), 
6.77 (1 H, d, J = 8.5, C2-CH or C2’-CH), 6.83 (1 H, dd, J = 8.5 and 3 Hz, C3-CH or C3’-CH), 6.84 (1 H, dd, J = 8.5 and 3, C3-CH or 
C3’-CH), 6.92 (1 H, d, J = 3, C5-CH or C5’-CH), 6.95 (1 H, d, J= 3, C5-CH or C5’-CH); C (67.5 MHz; acetone-d6) 27.3 (C9), 34.6 
(C8), 55.8 (2 x OMe), 62.1 (C10), 91.4 (C7’), 97.8 (C7), 111.1 (C2 or C2’), 112.1 (C2 or C2’), 117.5 (C3 or C3’), 117.6 (C3 or C3’), 
118.0 (C5 or C5’), 118.1 (C5 or C5’), 121.2 (C6 or C6’), 121.2 (C6 or C6’), 124.1 ((C6 or C6’), 145.6 (C4 or C4’), 146.8 (C4 or C4’), 
154.9 (C1 or C1’) and 155.3 (C1 or C1’); m/z (CI) Calcd for C19H21O6 [M+H
+] 345.13381; Found: 345.13381 (0 ppm). 
 
6H,12H-6,12-Di-(3’-carboxypropyl)-2,8-dimethoxy-6,12-epoxydibenzo[b,f][1,5]dioxocin 7 
 
A pre-cooled (ice bath) solution of Jones’ reagent was slowly dropped over an efficiently stirred solution of diol 5 (2.42 g, 6 mmol) in 
acetone (80 mL) at rt, maintaining a dropping rate such as the temperature does not rise 30 ºC. A green viscous precipitate is formed 
immediately. When the characteristic red-orange colour of the Jones’ reagent persists in the supernatant solution (TLC analysis shows 
total consumption of the starting material ca. 10 min), the reaction was stirred for additional 5 min at rt, quenched by addition of 
propan-2-ol (30 mL) and stirred until the precipitate became eventually a finely dispersed suspension (ca. 15 min). The crude product 
was filtered through a short Celite® pad (sintered glass), washing with acetone and EtOAc. The solvent was removed under reduced 
pressure and re-dissolved in EtOAc, washed with 10% HCl (2 x 50 mL), brine (50 mL) and dried over MgSO4. After filtration and 
removal of the solvent, the crude diacid was repeatedly evaporated with dichloromethane and finally triturated from PE to form a white 
amorphous solid of diacid 7 (2.45 g, 95%); Rf = 0.4 (EtOAc); max(film)/cm
-1 3000, 2952, 1705, 1497, 1425, 1277, 1225, 1173, 1080, 
1037, 933, 879, 818; H (270 MHz; acetone-d6) 2.4 (2 H, m), 2.71 (2 H, m), 2.47 (4 H, m), 3.73 (6 H, s, 2 x OCH3), 6.75 (2 H, d, J = 9, 
C2-CH, C2’-CH), 6.83 (2 H, dd, J = 9 and 3, C3-CH, C3’-CH) and 6.98 (2 H, d, J = 3, C5-CH, C5’-CH); C (125 MHz; acetone-d6) 
27.5 (C8, C8’), 32.5 (C9, C9’), 55.0 (2 x OMe), 96.7 (C7, C7’), 109.8 (C2, C2’), 116.9 (C3, C3’), 117.1 (C5, C5’), 122.2 (C6,  C6’), 
146.0 (C4, C4’), 155.4 (C1, C1’) and 173.2 (C10, C10’); m/z (FAB) HRMS Calcd for C22H22O9Na [M+Na
+] 453.11615; Found: 
453.11559 (+1.2 ppm). 
 
One-pot Friedel-Crafts acylation-desymmetrisation. General procedure 
 
A solution of diacid 7 (0.22 g, 0.5 mmol) in dry dichloromethane (15 mL) was cooled to 0 ºC (ice bath) under nitrogen and treated with 
DMF (1 drop, catalytic amount), followed by slow addition of oxalyl chloride (0.1 mL, 1.2 mmol). The mixture was warmed to room 
temperature and stirred for 1 h. Then, the solution was cooled again in an ice bath and diluted with DCM (15 mL), followed by 
12 
dropwise addition of a freshly prepared solution of aluminium chloride (0.49 g, 3.6 mmoL) in nitromethane (20 mL). The mixture was 
stirred at room temperature for 20 h and then quenched with 20% w/v aqueous solution of potassium sodium tartrate (50 mL) and 
stirred for additional 1 h. The mixture was diluted with DCM (15 mL) and extracted. The aqueous layers were diluted with 10% HCl 
for helping during separation of the layers, and the aqueous phase was washed with additional DCM (2 x 50 mL). The combined 
organic extracts were dried over sodium sulfate, filtered and solvent evaporated in vacuo. The crude product was loaded onto Celite® 
and purified by column chromatography on silica gel (eluting with a polar gradient, PE/EtOAc (7:3) to (1:1), (1:6) and finally (0:1)) to 
provide first the bis-phenolic compound 10 (0.060 g, 33%), followed by 9 (0.083 g, 44%) and finally the dimethoxy compound 8 (0.020 
g, 10%). All products were isolated as dark-reddish to pale pink powders after evaporation from cold diethyl ether. 
 
(a) 4H,11H-5,6,12,13-Tetrahydro-3,10-dimethoxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg][1,5]dioxocin-4,11-dione 8 
 
Rf = 0.28 (PE/EtOAc (1:6)); mp 227-229 ºC; max(film)/cm
-1 2937, 1685, 1590, 1481, 1438, 1238, 1184, 1048, 1006, 928, 869, 821; H 
(270 MHz; CDCl3) 2.40 (2 H, ddd, J = 19, 6.5 and 1, C2-CHb, C2’-CHb); 2.65 (2 H, ddd, J = 13, 6.5 and 1, C3-CHa, C3’-CHa), 2.84 (2 
H, ddd, J = 19, 6.5 and 1, C2-CHb, C2’-CHb), 3.16 (2 H, ddd, J = 19, 13 and 6.5, C2-CHa, C2’-CHa), 3.86 (6 H, s, 2 x OCH3), 6.96 (2 
H, d, J = 9, C8-CH, C8´-CH), 7.02 (2 H, d, J = 9, C7-CH, C7’-CH); C (67 MHz; CDCl3) 31.81 (C3, C3’), 34.33 (C2, C2’), 56.61 (2 x 
OMe), 93.3 (C4, C4’), 115.2 (C8, C8’), 118.9 (C), 122.9 (CH), 123.7 (CH2), 142.7 (C9, C9’), 154.5 (C6, C6’) and 194.9 (C1, C1’); m/z 
(CI) Calcd for C22H19O7 [M+H
+] 395.113078; Found: 395.112735 (+0.9 ppm). 
 
(b) 4H,11H-5,6,12,13-Tetrahydro-3-methoxy-10-hydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg][1,5]dioxocin-4,11-dione 9 
 
Rf = 0.5 (PE/EtOAc (1:6)); mp 213-214 ºC; max(film)/cm
-1 2963, 2839, 1686, 1648, 1591, 1478, 1298, 1274, 1184, 1046, 1007, 930, 
905; H (270 MHz; CDCl3) 2.44 (2 H, m), 2.67 (2 H, m), 2.85 (2H, m), 3.18 (1 H, ddd, J = 19, 13 and 6.5), 3.34 (1 H, ddd, J = 19, 13 
and 5.5), 3.87 (3H, s), 6.89 (1 H, d, J = 9 Hz), 6.98 (1 H, d, J = 9), 7.0 (1 H, d, J = 9), 7.05 (1 H, d, J = 9) and 11.68 (1 H, s); C (67 
MHz; CDCl3) 31.8 (CH2), 32.7 (CH2), 33.9 (CH2), 34.2 (CH2), 56.6 (CH3), 92.7 (C), 93.5 (C), 113.1 (C), 115.2 (CH), 119.1 (C), 120.1 
(C), 120.5 (CH), 122.7 (CH), 123.6 (C), 126.0 (CH), 141.7 (C), 142.3 (C), 154.5 (C), 157.2 (C), 194.7 (CO) and 202.3 (CO); m/z (CI) 
Calcd for C21H17O7 [M+H
+] 381.097428; Found: 381.096977 (+1.2 ppm). 
 
(c) 4H,11H-5,6,12,13-Tetrahydro-3,10-dihydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg][1,5]dioxocin-4,11-dione 10 
 
Rf = 0.68 (PE/EtOAc (1:6)); mp 232-234 ºC; max(film)/cm
-1 2975, 1644, 1621, 1593, 1469, 1326, 1317, 1264, 1227, 1187, 1084, 1050, 
898, 836; H (270 MHz; CDCl3) 2.46 (2 H, ddd, J = 13, 13 and 5.5), 2.70 (2 H, ddd, J = 13, 5.5 and 1.5), 2.87 (2 H, ddd, J = 19, 5.5 and 
1.5), 3.33 (2 H, ddd, J = 19, 13 and 5.5), 7.03 (2 H, d, J = 9), 6.91 (2 H, d, J = 9) and 11.69 (2 H, s); C (67 MHz; CDCl3) 32.2 (CH2), 
33.4 (CH2), 92.6 (C), 112.6 (C), 119.7 (C), 120.2 (CH), 125.5 (CH), 140.9 (C), 156.8 (C) and 201.9 (CO); m/z (CI) Calcd for C20H15O7 
[M+H+] 367.081778; Found: 367.081395 (+1.0 ppm). 
 
4H,11H-5,6,12,13-Tetrahydro-3-methoxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dione 12 
 
(a) A solution of phenol 9 (300 mg, 0.79 mmol) in DCM (6 mL) was cooled to –10 ºC (ice-salt bath) and treated with pyridine (0.60 
mL, 7.4 mmol), followed by slow addition of triflic anhydride (0.25 mL, 1.5 mmol). After stirring at room temperature for 4 hours, the 
reaction mixture was diluted with DCM (20 mL) and washed with saturated NaHCO3 solution (2 × 10 mL), 10% HCl (2 × 10 mL) and 
brine (10 mL). The organic extract was dried over Na2SO4, filtered and the solvent evaporated in vacuo, to provide the crude triflate 11, 
which was triturated from DCM/EtOAc/PE to afford a white amorphous solid which was used without further purification in the next 
step; Rf = 0.57 (PE/EtOAc (1:6)); H (500 MHz; CDCl3) 2.45 (1 H, ddd, J = 13, 13 and 6.5), 2.50 (1 H, ddd, J = 13, 13 and 6.5), 2.68 (1 
H, ddd, J = 13, 6 and 1), 2.73 (1 H, ddd, J = 13, 6 and 1), 2.86 (1 H, ddd, J = 19, 6 and 1), 2.93 (1 H, ddd, J = 19, 6 and 1), 3.18 (1 H, 
ddd, J = 19, 13 and 6.5), 3.27 (1 H, ddd, J = 19, 13 and 6.5), 3.87 (3H, s), 7.01 (1 H, d, J = 9.2), 7.08 (1 H, d, J = 9.2), 7.1 (1 H, d, J = 
9.2) and 7.21 (1 H, d, J = 9.2). 
 
(b) A suspension of the above crude triflate 11 in ethyl acetate/methanol (1:3 v/v, 24 mL) was treated with triethylamine (0.60 mL, 4.3 
mmol) at rt. Under nitrogen, Pearlman’s catalyst (20% palladium hydroxide on activated charcoal, 100 mg), was added. The flask was 
then purged with hydrogen and a sequential cycle vacuum-hydrogen was repeated several times. The mixture was stirred at room 
temperature for 24 h under a hydrogen atmosphere (light overpressure). The black suspension was bubbled with nitrogen and filtered 
through a short pad of Celite®, washing with ethyl acetate. The filtrate was washed with 10% hydrochloric acid (2 × 10 mL) and brine 
(10 mL), dried over Na2SO4 and evaporated in vacuo after filtration. The crude product was loaded onto Celite® and purified by flash 
column chromatography on silica gel (eluting with an PE/EtOAc (1:1)) to provide the title compound 12 as an pale white solid (0.236 g, 
82%); Rf = 0.53 (PE/EtOAc (1:6)); mp 162-165ºC; max(film)/cm
-1 2952, 2933, 2854, 1689, 1590, 1481, 1440, 1331, 1310, 1287, 1240, 
1206, 1185, 1091, 1050, 1010, 996, 898, 807, 734; H (500 MHz; CDCl3) 2.45 (1 H, ddd, J = 13.4, 13.2 and 6.7, C3-CHb), 2.47 (1 H, 
ddd, J = 13.4, 13 and 5.5, C3’-CHb), 2.68 (1 H, ddd, J = 13.4, 6.5 and 1.2, C3-CHa), 2.73 (1 H, ddd, J = 13.4, 5.8 and 1.5, C3’-CHa), 
2.83 (1 H, ddd, J = 19, 6.5 and 1.2, C2-CHb), 2.88 (1H, ddd, J = 19, 5.5 and 1.5, C2’-CHb), 3.20 (1 H, ddd, J = 19, 13 and 6.5, C2-CHa), 
3.26 (1 H, ddd, J = 19, 13.4 and 5.8, C2’-CHa), 3.87 (3 H, s, OCH3), 6.97 (1 H, d, J = 9.2, C8-CH), 7.043 (1 H, d, J = 9.2, C7-CH), 
7.045 (1 H, dd, J = 8 and 1, C7’-CH), 7.36 (1 H, t, J = 8, C8’-CH) and 7.59 (1 H, dd, J = 7.6 and 1, C9’-CH); C (100 MHz, CDCl3) 
31.8, 32.7, 33.7, 34.2, 56.5, 93.0, 93.7, 115.2, 120.5, 121.5, 122.5, 122.8, 123.5, 130.77, 130.79, 130.9, 142.3, 149.6, 154.4, 194.6 and 
195.9; m/z (EI) Calcd for C21H16O6 [M
+] 364.094688; Found: 364.094803 (-0.3 ppm). 
 
4H,11H-3-Methoxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dienone 15 
 
(a) A solution of 12 (345 mg, 1 mmol) in DCM (12 mL) under argon was treated with 2,6-lutidine (390 µL, 3.3 mmol) and TMSOTf 
(515 µL, 2.8 mmol) and stirred for 15 min at 0 ºC (ice bath) and then 1 h at rt. The reaction was quenched by dilution with DCM (10 
mL) and then washed with saturated NaHCO3 solution (10 mL). The aqueous layers were extracted with DCM (3 x 10 mL) and dried 
over MgSO4, filtered and the solvent evaporated at reduced pressure. The remaining traces of 2,6-lutidine were removed by azeotropic 
distillation under vacuo with toluene. The brownish oil 14 so generated was dried by azeotropic removal of the water traces with 
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acetonitrile, dried under high vacuum and used without further purification in the next step, Rf = 0.67 (PE/EtOAc (7:3)); H (400 MHz; 
CDCl3) 0.23 (9 H, s, SiMe3), 0.28 (9 H, s, SiMe3), 2.85-2.75 (3 H, m), 2.89 (1 H, dt, J = 16.8 and 6.4), 3.73 (3 H, s, OCH3), 5.23 (1 H, 
dd, J = 6.4 and 2.8, C2-CH), 5.27 (1 H, dd, J = 6 and 3.5, C2’-CH), 6.64 (1 H, d, J = 9), 6.67 (1 H, d, J = 8), 6.79 (1 H, d, J = 9), 7.01 
(1 H, dd, J = 7.6 and 1) and 7.18 (1 H, t, J = 8.2 and 7.6, C8’-CH); C (100 MHz; CDCl3) 0.0 (SiMe3), 0.16 (SiMe3), 32.9 (CH2), 33.2 
(CH2), 56.7 (OMe), 93.6, 94.7, 101.8, 103.7, 115.3, 115.5, 115.9, 116.2, 116.3, 117.8, 120.7, 130.1, 133.1, 144.1, 147.5, 147.8, 150.34 
and 150.45. 
 
(b) A solution of the crude bis-silyl enol ether 14 (1 mmol) in dry acetonitrile (12 mL) at rt under argon was treated with Pd(OAc)2 (470 
mg, 2.1 mmol) and stirred for 18 h. After filtration through a short Celite® pad (eluting CHCl3), the crude was purified by column 
chromatography on silica gel (eluting with a polar gradient PE/EtOAc (7:3) to (1:1)), affording the dienone 15 (312 mg, 91%) as a 
bright yellow solid, Rf = 0.38 (PE/EtOAc (1:1)); mp 206-208 ºC; max(film)/cm
-1 1671, 1634, 1589, 1484, 1475, 1432, 1339, 1291, 
1246, 1139, 1025, 943, 914, 833; H (400 MHz; CDCl3) 3.91 (3 H, s, OCH3), 6.54 (1 H, d, J = 10, C2-CH), 6.59 (1 H, d, J = 9.8, C2’-
CH), 7.05-6.95 (4 H, m, C3-CH, C7’-CH, C7-CH, C8-CH), 7.18 (1 H, d, J = 10, C3’-CH), 7.38 (1 H, dd, J = 8.2 and 7.6, C8’-CH) and 
7.61 (1 H, dd, J = 7.6 and 1.2, C9’-CH); C (100 MHz; CDCl3) 56.7, 89.7, 90.5, 115.5, 120.0, 120.2, 121.0, 121.2, 122.9, 129.8, 130.8, 
133.4, 135.2, 137.7, 140.8, 142.8, 149.8, 154.1, 182.5 and 183.5; m/z (EI) Calcd for C21H12O6 [M
+] 360.063388; Found: 360.063536 (-
0.4 ppm). 
 
4H,11H-5,6,12,13-Tetrahydro-3,6,13-trimethoxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dione 16 
 
Lithium methoxide (4.4 mg, 0.12 mmol) was added in one portion at rt under argon over a suspension of dienone 15 (7 mg, 0.02 mmol) 
in dry MeOH (1 mL) and stirred until complete solubilisation of the crude (ca 5 min) and further the beginning of the formation of a 
white precipitate. The reaction was quenched by addition of Celite® and elimination of the solvent. The residue was filtered in a 
sintered glass funnel and washed with dichloromethane. Elimination of solvent afforded the title compound 16 (8.2 mg, quantitative) as 
a white wax; Rf = 0.51 (PE/EtOAc (1:6)); max/(film) cm
-1 2928, 2846, 1690, 1591, 1480, 1335, 1284, 1114, 1093, 1042, 952, 917, 730; 
H (400 MHz; CDCl3) 3.03 (1 H, dd, J = 18.6 and 2, C2’-CHb), 3.07 (1 H, dd, J = 18 and 2.4, C2-CHb), 3.34 (1 H, dd, J = 18.3 and 3.6, 
C2’-CHa), 3.41 (1 H, dd, J = 18.3 and 3.3, C2-CHa), 3.526 (3 H, s, OCH3), 3.533 (3 H, s, OCH3), 3.87 (3 H, s, ArOCH3), 4.27 (1 H, dd, 
J = 3.3 and 2, C3’-CH), 4.34 (1 H, dd, J = 3 and 2.7, C3-CH), 6.98 (1 H, d, J = 9.2, C8-CH), 7.04 (1 H, dd, J = 8.2, C7’-CH), 7.04 (1 H, 
d, J = 9.2, C7-CH), 7.37 (1 H, t, J = 8, C8’-CH) and 7.63 (1 H, dd, J = 7.6 and 1, C9’-CH); C (100 MHz; CDCl3) 40.6, 41.2, 56.4, 
59.3, 59.4, 78.5, 79.4, 94.0, 94.7, 115.5, 118.5, 120.0, 120.4, 121.1, 121.7, 123.1, 131.0, 143.2, 150.3 (x2), 154.7, 192.4 and 193.8; m/z 
(CI) Calcd for C23H21O8 [M+H
+] 425.123643; Found: 425.122927 (+1.7 ppm). 
 
4H,11H-5,6,12,13-Tetrahydro-3-methoxy-5,13-dioxiran-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dione 17 
 
TBD (39.4 mg, 0.28 mmol) was added to a suspension of the dienone 15 (170 mg, 0.47 mmol) in dry toluene (15 mL) under argon at rt. 
After cooling to 0 ºC (ice bath), TBHP (5-6 M solution in decane, 1 mL) was added via microsyringe and the reaction warmed at rt. The 
original yellow suspension generated a pale brown solution. After 50 min, the reaction was quenched by addition of a saturated solution 
of sodium sulfite (15 mL) and diluted with EtOAc. The organic phase was separated and washed with brine. The combined aqueous 
layers were extracted with EtOAc (3 x 50 mL) and the organic extracts were dried over MgSO4 and filtered. After removal of the 
solvent, the residue was purified by flash column chromatography on silica gel (eluting with PE/EtOAc (1:1)). Diepoxide 17 was 
isolated as a viscous oil which was triturated from dichloromethane and excess PE affording a white fine powder (165 mg, 89%); Rf = 
0.51 (PE/EtOAc (1:1)); mp 116-118 ºC; max(film)/cm
-1 2940, 1702, 1592, 1486, 1336, 1289, 1252, 1160, 1034, 1011, 965, 878; H 
(400 MHz; CDCl3) 3.85 (3 H, s, OCH3), 3.89 (1 H, d, J = 4, C2-CH), 3.89 (1 H, d, J = 4.3, C2’-CH), 4.26 (1 H, d, J = 4.3, C3-CH), 4.3 
(1 H, d, J = 4, C3’-CH), 6.99 (1 H, d, J = 9.2, C8-CH), 7.04 (1 H, d, J = 9.2, C7-CH), 7.06 (1 H, dd, J = 7.9 and 1, C7’-CH), 7.42 (1 H, 
t, J = 8, C8’-CH) and 7.46 (1 H, dd, J = 7.6 and 1.5, C9’-CH); C (100 MHz; CDCl3) 52.3, 52.95, 53.1, 53.3, 56.6, 93.6, 94.3, 115.8, 
116.0, 120.9, 122.0, 122.9, 128.7, 131.9, 142.7, 149.9, 153.7, 190.6 and 192.1; m/z (CI) Calcd for C21H13O8 [M+H
+] 393.061043; 
Found: 393.061039 (+0 ppm). 
 
Reductive opening of -epoxy ketone 17 
 
(a) NaBH4 (37 mg, 1 mmol) was added in small portions to a suspension of (PhSe)2 (152 mg, 0.5 mmol) in absolute ethanol (4 mL) 
with stirring at room temperature under nitrogen. After vigorous evolution of hydrogen ceased, the colourless faint solution of 
Na[PhSeB(OEt)3] so generated was cooled to 0 °C (ice bath), and AcOH (67 µL, 1.2 mmol) was added via a microsyringe. The 
resulting mixture was further stirred for 5 min in the cold and used then without additional treatment. 
 
(b) 4H,11H-5,6,12,13-Tetrahydro-3-methoxy-6,13-dihydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dione 18 
 
A solution of thebis--epoxy ketone 17 (76 mg, 0.2 mmol) in EtOH/AcOH (1:1) v/v (2 mL) was added to the above solution at 0 ºC 
under nitrogen. The mixture was stirred at 0° C for 10 min and further for 45 min at rt. The reaction mixture was then opened to air for 
15 min and diluted with EtOAc. Brine was added and the aqueous layer extracted with EtOAc (3 x 25 mL). The combined organic 
layers were dried over MgSO4 and concentrated in vacuo after filtration. The crude residue was washed with 10 mL portions of PE and 
decanted and further purified by column chromatography on silica gel (using a polar gradient during the elution PE/EtOAc from (1:0) 
to (1:6)), affording 9-O-methoxy preussomerin L (18) as a pale yellow oil which was converted into a white solid by triturating from PE 
(51.4 mg, 67%); Rf = 0.22 (PE/EtOAc (1:6)); mp 203-205 ºC; max(film)/cm
-1 3336, 1695, 1677, 1588, 1481, 1432, 1332, 1274, 1083, 
1037; H (400 MHz; CDCl3, 40ºC) 2.32 (2 H, br s, 2 x OH), 2.98 (1 H, dd, J = 18.9 and 2.1, C2-CHb), 3.03 (1 H, dd, J = 18.6 and 2.4, 
C2’-CHb), 3.35 (1 H, dd, J = 18.9 and 4, C2-CHa), 3.41 (1 H, dd, J = 18.6 and 3.4, C2’-CHa), 3.87 (3 H, s, OCH3), 4.69 (1 H, m, C3-
CH), 4.77 (1 H, m, C3’-CH), 7.02 (1 H, d, J = 9.2, C8-CH), 7.08 (1 H, d, J = 9.2, C7-CH), 7.08 (1H, dd, J = 8.2 and 1, C7’-CH), 7.40 
(1 H, t, J = 8, C8’-CH) and 7.66 (1 H, dd, J = 7.6 and 1, C9’-CH); C (125 MHz; CDCl3) 41.4, 42.2, 56.5, 69.2, 70.1, 93.8, 94.5, 115.8, 
118.4, 119.2, 120.3, 120.7, 121.7, 123.1, 130.9, 131.3, 143.4, 150.6, 154.8, 192.0 and 193.45; m/z (CI) Calcd for C21H17O8 [M+H
+] 
397.09234; Found: 397.09182 (+1.1 ppm). 
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(c) 4H,11H-5,6,12,13-Tetrahydro-3-methoxy-5-oxiran-13-hydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-
dione 19 
 
The above solution (2 mL, 0.25 mmol) was added to a suspension of bis--epoxy ketone 17 (53 mg, 0.14 mmol) in EtOH/AcOH 
(1:0.2) v/v (1.2 mL) at rt under argon. After 25 min, the reaction was opened to air for 10 min, diluted with EtOAc (10 mL) and washed 
with brine. Aqueous layers were extracted with EtOAc (3 x 10 mL) and the combined organic fractions were dried over MgSO4, 
filtered and the solvent eliminated in vacuo. The residue was purified by column chromatography on silica gel (eluting with a polar 
gradient PE/EtOAc (7:3) to (1:6)), affording the starting material 17 (10 mg, 20%), epoxyalcohol 19 (29 mg, 54%), epoxyalcohol 20 
(3.4 mg, 7%) and diol 18 (5.7 mg, 11%), all as yellow waxy solids. The title compound 19 was converted into a white solid by 
triturating from PE; Rf = 0.35 (PE/EtOAc (1:1)); mp 268 ºC; max(film)/cm
-1 3471, 2917, 2848, 1694, 1592, 1485, 1439, 1337, 1285, 
1246, 1157, 1031, 1016, 954, 815; H (400 MHz; CDCl3) 2.43 (1 H, br s, 3’-OH), 3.04 (1 H, dd, J = 18.6 and 2.7, C2’-CHb), 3.57 (1 H, 
dd, J = 18.6 and 3.4, C2’-CHa), 3.86 (3 H, s, OCH3), 3.89 (1 H, d, J = 4.3, C3-CH), 4.22 (1 H, d, J = 4.3, C2-CH), 4.80 (1 H, m, C3’-
CH), 7.0 (1 H, d, J = 9.2, C8-CH), 7.07 (1 H, d, J = 9.2, C7-CH), 7.06 (1 H, dd, J = 8.2 and 1, C7’-CH), 7.41 (1 H, dd, J = 8.2 and  7.6, 
C8’-CH) and 7.67 (1 H, dd, J = 7.6 and 1, C9’-CH); C (100 MHz; CDCl3) 41.2, 53.0, 53.2, 56.6, 70.1, 94.13, 94.18, 115.93, 115.98, 
118.4, 119.1, 120.8, 121.6, 123, 130.8, 131.3, 143.1, 150.2, 153.7, 190.6 and 193.3; m/z (CI) Calcd for C21H15O8 [M+H
+] 395.07681; 
Found: 395.07625 (+1.1 ppm). 
 
4H,11H-5,6,13,13-Tetrahydro-3-methoxy-6-hydroxy-12-oxiran-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-dione 
20 
 
Rf = 0.2 (PE/EtOAc (1:1)); max(film)/cm
-1 3458, 2916, 2848, 1687, 1591, 1480, 1336, 1200, 1183, 1087, 1032, 962, 887, 735; H (400 
MHz; CDCl3) 3.0 (1 H, dd, J = 18.9 and 1.8, C2-CHb), 3.34 (1 H, dd, J = 18.9 and 4, C2-CHa), 3.88 (3 H, s, OCH3), 3.94 (1 H, d, J = 
4.3, C3-CH), 4.27 (1 H, d, J = 4.3, C2-CH), 4.74 (1 H, dd, J = 4 and 1.8, C3-CH), 7.01 (1 H, d, J = 9.2, C8-CH), 7.06 (1 H, d, J = 9.2, 
C7-CH), 7.09 (1 H, dd, J = 7.6 and 1.5, C7’-CH), 7.42 (1 H, t, J = 7.6, C8’-CH) and 7.46 (1 H, dd, J = 7.6 and 1.5, C9’-CH); C (100 
MHz; CDCl3) 42.1, 52.4, 53.4, 56.5, 69.3, 93.3, 94.6, 115.78, 115.90, 118.4, 120.3, 120.8, 122.0, 122.9, 128.8, 131.9, 143.1, 150.2, 
154.9, 191.7 and 192.1.  
 
Preussomerin L (4H,11H-5,6,12,13-Tetrahydro-3,6,13-trihydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4,11-
dione)  
 
9-I-BBN (1.0 M solution in hexanes, 62 µL, 0.062 mmol) was added dropwise at 0 ºC (ice-bath) under argon to a stirred suspension of 
the 9-methoxy-protected Preussomerin L (18) (24.8 mg, 0.062 mmol) in dry dichloromethane (5 mL). After 60 min, the reaction was 
quenched by addition of water (few drops). Stirring was continued and after 5 min, the crude was diluted with dichloromethane and 
brine and extracted. Aqueous layers were extracted furthermore with dichloromethane. The combined organic fractions were dried over 
anhydrous MgSO4, filtered, concentrated under reduced pressure and the resultant residue purified by column chromatography on silica 
gel (polar gradient PE/EtOAc = (1:1) to (1:6)) to afford Preussomerin L (9.8 mg, 42%) and recovered starting material 18 (6.6 mg, 
27%). Preussomerin L was a pale yellow viscous waxy solid which was converted into an amorphous white solid by solubilisation in 
dichloromethane followed by addition of PE and triturating. Analytically pure samples were prepared by recrystallisation from 
methanol affording colourless needles; Rf = 0.35 (PE/EtOAc (1:6)); mp 173-174 ºC; max(film)/cm
-1 3432, 2917, 2849, 1689, 1648, 
1469, 1085, 1041, 730; H (400 MHz; CDCl3) 2.26 (1 H, br s, 3’-OH), 2.33 (1 H, br s, 3-OH), 3.03 (1 h, dd, J = 18.3 and 2.7, C2’-CHb), 
3.05 (1 H, dd, J = 18.3 and 2.7, C2-CHb), 3.41 (1 H, dd, J = 18.3 and 3.2, C2’-CHa), 3.47 (1 H, dd, J = 18.3 and 3.2, C2-CHa), 4.76 (1 
H, m, C3-CH), 4.77 (1 H, m, C3’-CH), 6.96 (1 H, d, J = 9.2, C8-CH), 7.05 (1 H, d, J = 9.2, C7-CH), 7.11 (1 H, dd, J = 8.2 and 1, C7’-
CH), 7.44 (1 H, dd, J = 8, C8’-CH), 7.69 (1 H, dd, J = 7.6 and 1, C9’-CH) and 11.61 (1 H, br s, 9-OH); C (125 MHz; CDCl3) 41.2 
(C2/C2’), 41.4 (C2’/C2), 70.0 C3/C3’), 70.2 (C3’/C3), 94.06 (C4), 94.13 (C4’), 112.8 (C10), 117.1 (C5), 119.2 (C8), 120.8 (C9’/C8’), 
121.3 (C8’/C9’), 121.6 (C7’), 126.0 (C7), 130.9 (C5’/C10’), 131.3 (C10’/C5’), 142.5 (C6), 150.3 (C6’), 157.3 (C9), 193.3 (C1’) and 
199.6 (C1); m/z (CI) Calcd for C20H15O8 [M+H
+] 383.07669; Found: 383.07583 (+2.2 ppm). 
 
Preussomerin K (4H,11H-5,6,12,13-Tetrahydro-3,13-dihydroxy-5-oxiran-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-
4,11-dione) 
 
(a) Boron tribromide was added dropwise at -78 ºC under argon in three different portions every 15 min (two portions of 66 µL and a 
final portion of 200 µL; 0.33 mmol, 5 equiv.) to a solution of epoxyalcohol 19 (26 mg, 0.066 mmol) in dry dichloromethane (5 mL). 
After every addition of the Lewis acid, the reaction vessel was warmed at room temperature for 10 min and monitored by TLC. Once 
the TLC analysis showed total consumption of the starting material, the reaction was quenched with water (1 mL) and diluted with 
dichloromethane (10 mL). The aqueous layer was extracted with dichloromethane (3 x 10 mL) and the combined organic layers were 
dried over MgSO4. The solvent was eliminated in vacuo and dried under high vacuum. The crude material was analysed by NMR 
showing to be a mixture of bromohydrin 21 and preussomerin L in a proportion (8:2).  
 
Intermediate bromohydrin 21, H (400 MHz; CDCl3) 2.35 (1 H, br s, 3’-OH), 2.8 (1 H, br s, 3-OH), 3.04 (1H, dd, J = 18.3 and 3.4, C2’-
CHa), 3.39 (1H, dd, J = 18.3 and 3.4, C2’-CHb), 4.76 (1 H, d, J = 2, C2-CH), 4.77 (1 H, m, C3’-CH), 4.95 (1 H, d, J = 2, C3-CH), 7.0 (1 
H, d, J = 11.5, C8-CH), 7.12 (1 H, d, J = 11.5, C7-CH), 7.2 (1 H, dd, J = 10 and 1, C7’-CH), 7.45 (1 H, t, J = 10, C8’-CH), 7.7 (1 H, 
dd, J = 10 and 1, C9’-CH) and 11.45 (1 H, br s, 9-OH). 
 
(b) The above crude material was dissolved in absolute ethanol (1 mL) at room temperature under argon. Potasium tert-butoxide was 
added in one portion. The pale yellow solution turned dark brown immediately. After 45 min, TLC analysis showed complete 
transformation of the bromohydrin. The reaction was then quenched by addition of a 10% HCl solution (2 mL) and partitioned between 
water and dichloromethane. Aqueous layer was repeatedly washed with additional dichloromethane and finally the combined organic 
fractions were dried over MgSO4. After filtration and evaporation of the solvent, the subsequent residue was purified on silica gel 
(eluting with PE/EtOAc (1:1)), providing preussomerin L (4.4 mg, 17%), Rf = 0.1 (PE/EtOAc (1:1)), and preussomerin K (12.3 mg, 
50%), Rf = 0.35 (PE/EtOAc (1:1)) as a yellowish wax; max(film)/cm
-1 3362, 2916, 2848, 1692, 1662, 1594, 1470, 1270, 1088, 1023, 
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794; H (400 MHz; CDCl3) 2.41 (1 H, br s, 3’-OH), 3.05 (1 H, dd, J = 18.3 and 2.5, C2-CHb), 3.37 (1 H, dd, J = 18.3 and 3.4, C2’-
CHa), 3.86 (1 H, d, J = 4, C3-CH), 4.27 (1 H, d, J = 4, C2-CH), 4.80 (1 H, m, C3’-CH), 6.97 (1 H, d, J = 9.2, C8-CH), 7.06 (1 H, d, J = 
9.2, C7-CH), 7.09 (1 H, dd, J = 8.2 and 1, C7’-CH), 7.43 (1 H, t, J = 8, C8’-CH), 7.69 (1 H, dd, J = 7.7 and 1, C9’-CH) and 10.16 (1 H, 
br s, 9-OH); C (125 MHz, CDCl3) 41.2 (C2’), 52.1 (C3), 53.5 (C2), 70.2 (C3’), 93.7 (C4), 94.4 (C4’), 110,2 (C10), 115.6 (C5), 119.2 
(C5’), 120.8 (C7), 121.41 (C9’), 121.46 (C7’), 126.5 (C8), 130.7 (C10’), 131.3 (C8’), 142.77 (C6), 149.8 (C6’), 156.2 (C9), 193.1 
(C1’) and 195.4 (C1); m/z (CI) Calcd for C20H13O8 [M+H
+] 381.061043; found: 381. 060608 (+1.1 ppm). 
 
4H,11H-5,6,11,12,13-Pentahydro-3-methoxy-11-hydroxy-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-one 22  
 
A suspension of the crude triflate 11 (0.65 mmol) in EtOAc/methanol (1:3 v/v, 24 mL) was treated with triethylamine (550 µL). Under 
nitrogen, Pd/C (5% Palladium on activated charcoal, 200 mg) was added. The flask was then purged with hydrogen and committed to a 
sequential cycle vacuum-hydrogen repeated several times. The mixture was stirred at room temperature for 20 h under a hydrogen 
atmosphere (balloon). The black suspension was then purged with nitrogen and filtered through a short Celite® pad, washing with 
EtOAc. The filtrate was loaded onto Celite® and purified by flash column chromatography on silica gel (eluting with a polar gradient 
PE/EtOAc (1:1) to (1:6)) to provide the title compound 22 as an white solid (117 mg, 50%); Rf = 0.43 (PE/EtOAc (1:6)); mp 132-134 
ºC; max(film)/cm
-1 3426, 2962, 2884, 1680, 1590, 1480, 1285, 1187, 1048, 1009, 916, 808; H (400 MHz; CDCl3) 2.11 (1 H, m, C2’-
CHb), 2.6-2.3 (4 H, m, C3-CHb, C3’-CHa, C3’-CHb, C2’-CHa), 2.62 (1 H, ddd, J = 13, 6.5 and 1.5, C3-CHa), 2.82 (1 H, ddd, J = 19, 6.7 
and 1.5, C2-CHb), 3.20 (1 H, ddd, J = 19, 13 and 6, C2-CHa), 3.86 (3 H, s, OCH3), 4.85 (1 H, m, C1’-CH), 6.73 (1 H, dd, J = 8.2 and 1, 
C7’-CH), 6.95 (1 H, d, J = 9.2, C8-CH), 7.03 (1 H, d, J = 9.2, C7-CH), 7.08 (1 H, ddd, J = 7.6, 1 and 0.6, C9’-CH) and 7.25 (1 H, dd, J 
= 8.2 and 7.6, C8’-CH); a selective 1D-NOESY was found at peak  7.08 ppm (C9’-CH, 4.1%) when irradiating at  4.85 ppm (C1’-
CH); C (100 MHz; CDCl3) 194.9, 154.3, 149.7, 142.3, 139.3, 130.75 (C8’), 123.9, 122.6 (C7), 121.2 (C9’), 118.7, 117.8, 115.4 (C7’), 
115.0 (C8), 94.2, 93.2, 68.2 (C1’), 56.5 (OMe), 34.3 (C2), 31.93 (C3), 31.88 (C2’), 28.2 (C3’); m/z (CI) Calcd for C21H19O6 [M+H
+] 
367.118164; Found: 367.118239 (-0.2 ppm).  
 
4H,11H-5,6,11,12,13-Pentahydro-3-methoxy-11-(methoxy-methoxy)-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-one 
25a 
 
A solution of 22 (95 mg, 0.26 mmol) in dry dichloromethane (10 mL) was cooled to 0 ºC under argon and treated with Hunig’s base 
(160 µL, 0.91 mmol). Then, chloromethyl methyl ether (CAUTION, cancer suspected agent, 60 µL, 0.78 mmol) was added 
portionwise. The reaction was stirred at 0 ºC for 1h. The crude was warmed to rt and stirred until completion (TLC analysis, ca. 1 h), 
quenched by addition of saturated NH4Cl solution (30 mL) and extracted with DCM (3 x 25 mL). The combined organic extracts were 
washed with brine (30 mL), dried over MgSO4, filtered and the solvent eliminated under reduced pressure. The crude product was 
purified by column chromatography on silica gel (eluting with a polar gradient PE/EtOAc (1:1) to (1:6)) affording the title compound 
25a as a white wax (100 mg, 94%); Rf = 0.54 (PE/EtOAc (1:6)); max(film)/cm
-1 2934, 1683, 1591, 1480, 1464, 1285, 1239, 1149, 
1101, 1037, 1007, 919, 810, 746; H (400 MHz; CDCl3) 2.11 (1 H, m, C2’-CHb), 2.7-2.3 (5 H, m, C3-CHa, C3-CHb, C3’-CHa, C3’-
CHb, C2’-CHa), 2.81 (1 H, ddd, J = 19, 6.5 and 1.5, C2-CHb), 3.5 (3 H, s, MOM-CH3), 3.19 (1 H, ddd, J = 19, 13 and 6, C2-CHa), 3.86 
(3 H, s, OCH3), 4.78 (1 H, d, J = 7, MOM-CHb), 4.84 (1 H, m, C1’-CH), 4.9 (1 H, d, J = 7, MOM-CHa), 6.71 (1 H, dd, J = 8.2 and 1, 
C7’-CH), 6.94 (1 H, d, J = 9.2, C8-CH), 7.04 (1 H, d, J = 9.2, C7-CH), 7.06 (1 H, ddd, J = 7.6, 1 and 0.6, C9’-CH) and 7.23 (1 H, t, J = 
8, C8’-CH); C (100 MHz; CDCl3) 25.8 (C3’), 32.0 (C2’), 32.6 (C3), 34.4 (C2), 55.8 (OCH3), 56.5 MOM-CH3), 73.0 (C1’), 93.1, 93.7, 
95.4 (MOM-CH2), 114.9 (C8), 115.2 (C7’), 118.5, 121.8 (C9’), 122.9 (C7), 123.8, 130.3 (C8’), 136.9, 142.5, 149.7, 154.1 and 195.0 
(C1); m/z (CI) Calcd for C23H23O7 [M+H
+] 411.144378; Found: 411.144043 (+0.8 ppm). 
 
4H,11H-5,6,11,12,13-Pentahydro-3-hydroxy-11-(methoxy-methoxy)-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-one 
25b 
 
A solution of ketone 25a (26 mg, 0.06 mmol) was dissolved in dry pyridine (2 mL) under argon and was treated with LiI (42 mg, 0.31 
mmol) and heated under reflux for 20 h protected from direct light (aluminium foil). After cooling to rt, the reaction was quenched by 
addition of water and acidified carefully with 10% HCl solution. The aqueous layer was extracted with DCM (3 x 25 mL), the 
combined organic layers washed with brine and dried over MgSO4, filtered and solvent eliminated in vacuo. The residue was purified 
by column chromatography on silica gel (PE/EtOAc (1:1)), affording title compound 25b (23.2 mg, 93%) as a waxy solid; Rf = 0.63 
(PE/EtOAc (1:1)); max(film)/cm
-1 2938, 2889, 2771, 1648, 1622, 1593, 1469, 1365, 1324, 1300, 1276, 1225, 1184, 1148, 1100, 1037, 
1006, 917, 808, 750, 733; H (400 MHz; CDCl3) 2.07 (1 H, m, C3’-CHb), 2.65-2.35 (4 H, m, C3-CHb, C2’-CHa, C2’-CHb, C3’-CHa), 
2.64 (1 H, ddd, J = 13.2, 5.6 and 1.8, C3-CHa), 2.84 (1 H, ddd, J = 18.5, 5.2 and 1.8, C2-CHb), 3.33 (1 H, ddd, J = 18.5, 13.7 and 5.6, 
C2-CHa), 3.51 (3 H, s, MOM-OCH3), 4.79 (1 H, d, J = 7, CH2MOM), 4.83 (1 H, m, C1’-CH), 4.9 (1 H, d, J = 7, CH2-MOM), 6.73 (1 
H, d, J = 8.2, C7’-CH), 6.87 (1 H, d, J = 9.1, C8-CH), 7.03 (1 H, d, J = 9.1, C7-CH), 7.08 (1 H, d, J = 7.6, C9’-CH), 7.24 (1 H, t, J = 8, 
C8’-CH) and 11.7 (1 H, s, C9-OH); C (100 MHz; CDCl3) 25.5 (C3’), 32.3 (C2’), 32.6 (C3), 33.6 (C2), 55.7(OCH3-MOM), 73.1 (C1’), 
92.7, 94.1, 95.6 (CH2-MOM), 113, 115.3 (C7’), 118.7, 120.3, 120.5, 122 (C8), 126.4, 130.6, 137.3 (C7), 141.8, 149.7, 157.2 (C8’) and 
203.1 (C1); m/z (CI) Calcd for C22H21O7 [M+H
+] 397.128728; Found: 397.128037 (+1.7 ppm). 
 
4H,11H-5,6,11,12,13-Pentahydro-3,11-di(methoxy-methoxy)-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-one 25c 
 
A solution of 25b (34 mg, 0.085 mmol) in dry dichloromethane (4 mL) was cooled to -10 ºC under argon and treated with Hunig’s base 
(52 µL, 0.3 mmol). Then, chloromethyl methyl ether (CAUTION, cancer suspected agent; 20 µL, 0.26 mmol) was added portionwise. 
The reaction was stirred at 0 ºC for 1 h and then warmed to rt and stirred for 12 h. More Hunig’s base (52 µL, 0.3 mmol) and 
chloromethyl methyl ether (20 µL, 0.26 mmol) were added and stirred at rt for further 12 h, then quenched by addition of saturated 
NH4Cl solution (20 mL) and extracted with DCM (3 x 20 mL). The combined organic extracts were washed with brine (20 mL), dried 
over MgSO4, filtered and the solvent eliminated under reduced pressure. The crude product was purified by column chromatography on 
silica gel (eluting with PE/EtOAc (1:1)), affording the title compound 25c as a white wax (32 mg, 75%); Rf = 0.43 (PE/EtOAc (1:1)); 
max(film)/cm
-1 2953, 2899, 1689, 1591, 1476, 1284, 1192, 1150, 1036, 1006, 990, 919, 810, 733; H (400 MHz; CDCl3) 2.07 (1 H, m, 
C3’-CHb), 2.65-2.35 (5 H, m, C3-CHa, C3-CHb, C2’-CHa, C3’-CHa, C3’-CHb), 2.8 (1 H, ddd, J = 18.8, 6.4 and 1.3, C2-CHb), 3.18 (1 
16 
H, ddd, J = 18.8, 13.2 and 6.3, C2-CHa), 3.487 (3 H, s, MOM-OCH3), 3.494 (3 H, s, MOM-OCH3), 4.76 (1 H, d, J = 7, CHb-MOM), 
4.83 (1 H, m, C1’-CH), 4.87 (1 H, d, J = 7, CHa-MOM), 5.15 (1 H, d, J = 6.9, CHb-MOM-Ar), 5.19 (1 H, d, J = 6.9, CHa-MOM-Ar), 
6.71 (1 H, d, J = 7.9, C7’-CH), 7.0 (1H, d, J = 9.1, C8-CH), 7.06 (1 H, d, J = 7.6, C9’-CH), 7.15 (1 H, d, J = 9.1, C7-CH) and 7.23 (1 
H, t, J = 8, C8’-CH); C (100 MHz; CDCl3) 25.4, 31.8, 32.3, 34.2, 55.7, 56.3, 72.9, 93.0, 93.9, 95.4, 96.3, 115.5, 118.7, 120.3, 120.8, 
122.4, 122.9, 123.7, 130.2, 137.2, 144.3, 150.0, 151.8 and 195.4; m/z (CI) Calcd for C24H25O8 [M+H
+] 441.154943; Found: 441.154622 
(+0.7 ppm). 
 
4H,11H-11,12,13-Trihydro-3,11-di(methoxy-methoxy)-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-one 26c 
 
(a) Sodium hexamethyldisilazane (1.0 M solution in THF, 28 µL, 0.028 mmol) was added portionwise via microsirynge to a solution of 
the protected intermediate 25c (10.2 mg, 0.023 mmol) in dry THF (2 mL) under argon at -40ºC and stirred for 15 min. The deep orange 
solution of the enolate so generated was trapped with TMSCl (6 µL, 0.05 mmol) and slowly warmed to -10 ºC, then to 0 ºC and finally 
to rt over 5 h. Reaction crude was concentrated under reduced pressure and the crude product was efficiently dried under high vacuum, 
affording a yellow viscous oil which was used without further purification in the next step. 
 
(b) The above crude silyl enol ether was dissolved (solubilisation assisted by sonication) in dry acetonitrile (2 mL) at rt under argon and 
Pd(OAc)2 (6.2 mg, 0.028 mmol) was added in one portion. The reaction was stirred for 15 h. After filtration through a short Celite® 
pad (EtOAc washings), the solvent was eliminated and the residue purified by column chromatography on silica gel (eluting PE/EtOAc 
(7:3)), affording the hydrolysed starting material 25c (2.5 mg, 25%) and the title enone 26c (7.6 mg, 75%) as a waxy viscous solid; Rf = 
0.4 (PE/EtOAc (1:1)); max(film)/cm
-1 2951, 2913, 1675, 1591, 1480, 1338, 1287, 1244, 1201, 1150, 1085, 1036, 1006, 990, 918, 808; 
H (400 MHz; CDCl3) 2.07 (1 H, m, C3’-CHb), 2.6-2.4 (3 H, m, C2’-CHa, C2’-CHb, C3’-CHa), 3.50 (3 H, s, MOM-OCH3), 3.51 (3 H, s, 
MOM-OCH3), 4.82 (1 H, d, J = 7, CHb-MOM), 4.93 (1 H, d, J = 7, CHa-MOM), 4.83 (1 H, m, C1’-CH), 5.19 (1 H, d, J = 6.9, CHb-
MOM-Ar), 5.24 (1 H, d, J = 6.9, CHa-MOM-Ar), 6.47 (1 H, d, J = 10, C2-CH), 6.72 (1 H, d, J = 8, C7’-CH), 6.98 (1 H, d, J = 9.2, C8-
CH), 7.0 (1 H, d, J = 10, C3-CH), 7.09 (1 H, d, J = 7.7, C9’-CH), 7.16 (1 H, d, J = 9.2, C7-CH) and 7.24 (1 H, t, J = 8, C8’-CH); C 
(100 MHz; CDCl3) 25.6, 32.3, 55.7, 56.4, 73.2, 94.4, 95.8, 96.6, 115.6, 118.1, 119.2, 121.0, 121.7, 122.8, 130.7, 134.9, 137.1, 139.5, 
144.7, 150.0, 151.8 and 183.7; m/z (CI) Calcd for C24H23O8 [M+H
+] 439.139293; Found: 439.139026 (+0.6 ppm). 
 
4H,11H-5,6,11,12,13-Pentahydro-3,11-di(methoxy-methoxy)-5-oxiran-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] [1,5]dioxocin-4-
one 27c 
 
TBD (1 mg, 0.006 mmol) was added to a solution of the enone 26c (9.4 mg, 0.02 mmol) in dry toluene (1.2 mL) under argon at rt. After 
cooling at 0 ºC (ice bath), TBHP (5-6 M solution in decane, 24 µL) was added via microsyringe and the reaction warmed to rt. The 
original yellow solution turned off in a colourless solution. After 40 min, the reaction was quenched by addition of a saturated solution 
of sodium sulfite (2 mL) and diluted with EtOAc. The organic phase was separated and washed with brine. The combined aqueous 
layers were extracted with EtOAc (3 x 10 mL) and the combined organic extracts dried over MgSO4 and filtered. After removal of the 
solvent, the residue was purified by flash column chromatography on silica gel (eluting with PE/EtOAc (7:3)). Epoxide 27c was 
isolated as a colourless wax (8.5 mg, 89%); Rf = 0.39 (PE/EtOAc (1:1)); max(film)/cm
-1 2959, 2944, 2926, 2825, 1704, 1591, 1483, 
1287, 1153, 1037, 923, 808, 733; H (400 MHz; CDCl3) 2.11 (1 H, m, C3’-CHb), 2.65-2.4 (3 H, m, C2’-CHa, C2’-CHb, C3’-CHa), 3.48 
(3 H, s, MOM-OCH3), 3.50 (3 H, s, MOM-OCH3), 3.83 (1 H, d, J = 4.4, C2-CH), 4.12 (1 H, d, J = 4.4, C3-CH), 4.78 (1 H, d, J = 7, 
MOM-CHb), 4.83 (1 H, m, C1’-CH), 4.89 (1 H, d, J = 7, MOM-CHa), 5.13 (1 H, d, J = 6.9, CHb-MOM-Ar), 5.18 (1 H, d, J = 6.9, CHa-
MOM-Ar), 6.7 (1 H, d, J = 8.2, C7’-CH), 7.01 (1 H, d, J = 9.2, C7-CH), 7.1 (1 H, d, J = 7.6, C9’-CH),7.19 (1 H, d, J = 9.2, C7-CH), 
7.25 (1 H, t, J = 7.9, C8’-CH); C (100 MHz; CDCl3) 25.0, 31.8, 52.8, 53.3, 55.5, 56.2, 72.9, 93.6, 94.5, 95.8, 96.3, 115.8, 117.8, 118.9, 
121.1, 122.9, 123.5, 131.3, 135.4, 137.9, 145.9, 149.8 and 192.7; m/z (CI) Calcd for C24H22O9 [M+H
+] 454.126383; Found: 455.126429 
(-0.1 ppm). 
 
Preussomerin F (4H,11H-5,6,11,12,13-Pentahydro-3,11-didihydroxy-5-oxiran-6a,13a-epoxydinaphtho[1,8-bc:1’,8’-fg] 
[1,5]dioxocin-4-one) 
 
A dilute solution of HCl in isopropyl alcohol was prepared prior to use by dropping concentrated HCl (3 drops, ca 60 µL) in isopropyl 
alcohol (10 mL). The MOM-protected epoxyketone 27c (4.8 mg, 0.01 mmol) was dissolved in 2 mL of this freshly prepared solution 
and heated at 50 ºC for 8 h under argon. The reaction was quenched by addition of solid NaHCO3, diluted with EtOAc and filtered 
through a short cotton pad, washing with additional EtOAc. The solvent was eliminated and the residue purified further by column 
chromatography on silica gel (eluting PE/EtOAc polar gradient (7:3) to (1:1)) affording the desired deprotected title compound 
Preussomerin F (2.4 mg, 66%) and diol 29 (1.3 mg, 34%) as waxy solids; Preussomerin F, Rf = 0.32 (PE/EtOAc (1:1)); max(film)/cm
-
1 3435, 3374, 2961, 2929, 2860, 1659, 1633, 1592, 1469, 1363, 1315, 1262, 1091, 1023, 801, 734; H (400 MHz; CDCl3) 2.11 (1 H, 
ddd, J = 17.7, 13.2 and 6.4, C2’-CHb), 2.5-2.45 (2 H, m, C3’-CHa, C3’-CHb), 2.61 (1 H, ddd, J = 17.7, 13.2 and 4.4, C2’-CHa), 3.80 (1 
H, d, J = 4.0, C2-CH), 4.16 (1 H, d, J = 4.0, C3-CH), 4.86 (1 H, m, C1’-CH), 6.74 (1 H, d, J = 8, C7’-CH), 6.92 (1 H, d, J = 9.1, C7-
CH), 7.04 (1 H, d, J = 9.1, C8-CH), 7.17 (1 H, d, J = 7.6, C9’-CH), 7.28 (1 H, t, J = 7.9, C8’-CH) and 10.16 (1 H, s, C9-OH); H (400 
MHz; methanol-d4) 2.1-2.0 (1 H, m, C2’-CHb), 2.5-2.3 (3 H, m, C2’-CHa, C3’-CHa, C3’-CHb), 3.84 (1 H, d, J = 4, C3-CH), 4.26 (1 H, 
d, J = 4, C3-CH), 4.8 (1 H, m, C1’-CH), 6.72 (1 H, d, J = 7.6, C7’-CH), 6.91 (1 H, d, J = 9.2, C7-CH), 7.08 (1 H, d, J = 9.2, C8-CH), 
7.17 (1 H, d, J = 8, C9’-CH) and 7.24 (1 H, d, J = 8, C8’-CH); C (100 MHz; CDCl3) 28.4, 32.1, 52.1, 53.8, 68.2, 93.1, 94.9, 110.1, 
115.2, 115.9, 127.8, 120.8, 121.6, 126.4, 130.9, 139.2, 143.2, 148.6, 155.6 and 195.8; C (100 MHz; methanol-d4) 29.4 (C3’), 30.8 
(C2’), 53.2 (C3), 54.9 (C2), 68.4 (C1’), 94.6 (C4’), 96.2 (C4), 111.6 115.6 (C7’), (C5), 116.6 (C10), 118.9 (C9’), 119.2 (C5’), 121.7 
(C7), 127.2 (C8), 131.9 (C8’), 141.4 (C10’), 144.7 (C6), 150.0 (C6’), 156.3 (C9) and 197.4 (C1); m/z (EI) Calcd for C20H14O7 [M
+] 
366.073953; Found: 366.074153 (-0.5 ppm). 
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